Terms: = Bone cancer AND TPM3, ENSG00000143549, 7170 AND Prognosis
5 results:
1. Establishment and validation of a competitive risk model for predicting cancer-specific survival in patients with osteosarcoma: a population-based study.
Wu X; Wang J; He D
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15383-15394. PubMed ID: 37639006
[TBL] [Abstract] [Full Text] [Related]
2. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
[TBL] [Abstract] [Full Text] [Related]
3. A Clinical Model of bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, prognosis, and Treatment.
Wang B; Chen LJ; Wang XY
Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of prognostic nomograms for patients with metastatic prostate cancer.
Jiang WD; Yuan PC
Int Urol Nephrol; 2019 Oct; 51(10):1743-1753. PubMed ID: 31289983
[TBL] [Abstract] [Full Text] [Related]
5. Surgical treatment of 21 patients with spinal metastases of differentiated thyroid cancer.
Jiang L; Ouyang H; Liu X; Wei F; Wu F; Dang L; Liu Z
Chin Med J (Engl); 2014; 127(23):4092-6. PubMed ID: 25430455
[TBL] [Abstract] [Full Text] [Related]
